Smith, Moore & Co. Revolution Medicines, Inc. Put Options Transaction History
Smith, Moore & Co.
- $1.17 Billion
- Q3 2025
Put Options
0 transactions
| Quarter | Operation | Price Per put | puts change | puts Held | SEC Form |
|---|
Others Institutions Holding RVMD
# of Institutions
343Shares Held
197MCall Options Held
878KPut Options Held
693K-
Vanguard Group Inc Valley Forge, PA15.7MShares$1.01 Billion0.01% of portfolio
-
Farallon Capital Management LLC San Francisco, CA14.6MShares$942 Million2.96% of portfolio
-
Black Rock Inc. New York, NY13.4MShares$863 Million0.01% of portfolio
-
Janus Henderson Group PLC London, X011.4MShares$731 Million0.26% of portfolio
-
Wellington Management Group LLP Boston, MA9.81MShares$632 Million0.08% of portfolio
About Revolution Medicines, Inc.
- Ticker RVMD
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 87,697,600
- Market Cap $5.65B
- Description
- Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...